Oestrogen as a calcium channel blocker.

This paper reviews the evidence for calcium-antagonist properties of oestrogen which may offer long-term protective effects on the cardiovascular system in postmenopausal women. Oestrogen has already been shown to have a beneficial effect on cholesterol metabolism and deposition, thereby inhibiting the formation of atherosclerotic plaque and coronary atheroma. Calcium antagonism, resulting in both acute and chronic modulation of coronary and peripheral vasomotion, is another mechanism by which oestrogens may provide cardiovascular benefits to women, including those with existing cardiovascular disease.

[1]  R. Cohen,et al.  Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. , 1990, The Journal of clinical investigation.

[2]  A. Brown,et al.  The agonist effect of dihydropyridines on Ca channels , 1984, Nature.

[3]  J. Rosazza,et al.  Role of 4-hydroxylated estradiol in reducing Ca2+ uptake of uterine arterial smooth muscle cells through potential-sensitive channels. , 1987, Biology of reproduction.

[4]  Robert M. Rapoport,et al.  Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation , 1983, Nature.

[5]  P. Poole‐Wilson,et al.  Estradiol-17β Attenuates Acetylcholine-Induced Cor-onary Arterial Constriction in Women but not Men with Coronary Heart Disease: S-5. , 1995 .

[6]  J. Rosazza,et al.  Interaction of 4-hydroxylated estradiol and potential-sensitive Ca2+ channels in altering uterine blood flow during the estrous cycle and early pregnancy in gilts. , 1987, Biology of reproduction.

[7]  J. Sowers,et al.  17 beta-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. , 1994, The American journal of physiology.

[8]  B. Antuna.  Postmenopausal use of estrogen and occlusion of coronary arteries , 1988 .

[9]  Y. Ouchi,et al.  17β-Estradiol Inhibits Ca2+ Influx and Ca2+ Release Induced by Thromboxane A2 in Porcine Coronary Artery , 1995 .

[10]  P. Collins,et al.  Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. , 1994, Circulation.

[11]  S. Manuck,et al.  Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. , 1990, Arteriosclerosis.

[12]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[13]  D. Rader,et al.  Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women , 1994, The Lancet.

[14]  Estrogen and coronary heart disease in women. , 1991 .

[15]  P. Poole‐Wilson,et al.  Effect of 17 beta-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. , 1992, British journal of pharmacology.

[16]  P Théroux,et al.  A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. , 1990, Circulation.

[17]  J. Barboriak,et al.  Postmenopausal use of estrogen and occlusion of coronary arteries. , 1988, American heart journal.

[18]  D. Yang,et al.  Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. , 1992, American journal of obstetrics and gynecology.

[19]  I. Godsland,et al.  Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. , 1987, American heart journal.

[20]  E. Barrett-Connor,et al.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. , 1987, Circulation.

[21]  A. Quyyumi,et al.  Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. , 1994, Circulation.

[22]  L. Ignarro,et al.  Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  W. Willett,et al.  Menopause and the risk of coronary heart disease in women. , 1987, The New England journal of medicine.

[24]  G. Lemp,et al.  Postmenopausal estrogen use and coronary atherosclerosis. , 1988, Annals of internal medicine.

[25]  G. Colditz,et al.  Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆ , 1991 .

[26]  P. Poole‐Wilson,et al.  Effect of 17β‐oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea‐pig isolated cardiac myocytes , 1992 .

[27]  P. Poole‐Wilson,et al.  Cardiovascular protection by oestrogen—a calcium antagonist effect? , 1993, The Lancet.

[28]  M. Lewis,et al.  Endothelium‐derived relaxing factor alters calcium fluxes in rabbit aorta: a cyclic guanosine monophosphate‐mediated effect. , 1986, The Journal of physiology.

[29]  S. Reis,et al.  Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. , 1994, Circulation.

[30]  P. Poole‐Wilson,et al.  Endothelium‐independent relaxation of rabbit coronary artery by 17β‐oestradiol in vitro , 1991, British journal of pharmacology.

[31]  G. Rosano,et al.  Estrogen acutely increases peripheral blood flow in postmenopausal women. , 1995, The American journal of medicine.

[32]  I. Charles,et al.  Induction of calcium-dependent nitric oxide synthases by sex hormones. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Quyyumi,et al.  Acute Vascular Effects of Estrogen in Postmenopausal Women , 1994, Circulation.

[34]  Stamatis Adamopoulos,et al.  17β-Estradiol Attenuates Acetylcholine-Induced Coronary Arterial Constriction in Women but Not Men With Coronary Heart Disease , 1995 .

[35]  S. Kharitonov,et al.  Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. , 1994, British heart journal.

[36]  J. Deckers,et al.  Retardation of angiographic progression of coronary artery disease by nifedipine , 1990, The Lancet.

[37]  E. Barrett-Connor,et al.  Estrogen and coronary heart disease in women , 1991, JAMA.

[38]  P. Sarrel.  Ovarian hormones and the circulation. , 1990, Maturitas.

[39]  P. D. Henry,et al.  Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine. , 1981, The Journal of clinical investigation.

[40]  M. Valverde,et al.  Novel plasma membrane action of estrogen and antiestrogens revealed by their regulation of a large conductance chloride channel , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.